Identification of the receptor for advanced glycation end products in synovial tissue of patients with rheumatoid arthritis

被引:44
|
作者
Drinda, S [1 ]
Franke, S
Rüster, M
Petrow, P
Pullig, O
Stein, G
Hein, G
机构
[1] Univ Jena, Dept Internal Med 4, D-6900 Jena, Germany
[2] Univ Jena, Inst Pathol, D-6900 Jena, Germany
[3] Univ Erlangen Nurnberg, Div Orthoped Rheumatol, Erlangen, Germany
[4] Univ Jena, Klin Innere Med 4, D-07740 Jena, Germany
关键词
immunohistochemistry; receptor for advanced glycation end products (RAGE); rheumatoid arthritis; synovial tissue;
D O I
10.1007/s00296-004-0456-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Generation of advanced glycation end products ( AGE) is an inevitable process in vivo and can be accelerated under pathologic conditions such as oxidative stress, e. g. in rheumatoid arthritis ( RA). This process is mediated by the AGE-specific receptor ( RAGE). In this study we analysed the presence of RAGE in RA and osteoarthritic (OA) synovial tissue using immunohistology. Methods: Frozen synovial tissue samples from 11 RA patients and 12 OA patients were treated with goat anti-RAGE immunoglobulin G (IgG) and rabbit antigoat IgG. Immunostaining was visualised with streptavidin horse radish peroxidase ( chromogen amino-ethyl-carbazole). Cell differentiation was performed with antibodies against CD68, CD45RO, and CD20. Results: In 9/11 RA and 8/12 OA synovial specimens, RAGE was detected in synovial lining, sublining, and stroma. In RA, many T cells ( CD45RO(+)) and some macrophages ( CD68(+)) showed positive immunostaining for RAGE, whereas B cells were mostly negative. We found no difference in staining patterns between the RA and OA samples. Conclusions: We detected RAGE in RA and OA synovial tissue. The presence of RAGE on macrophages, T cells, and some B cells suggests its role in the pathogenesis of inflammatory joint disease.
引用
收藏
页码:411 / 413
页数:3
相关论文
共 50 条
  • [1] Identification of the receptor for advanced glycation end products in synovial tissue of patients with rheumatoid arthritis
    Stefan Drinda
    Sybille Franke
    Michael Rüster
    Peter Petrow
    Oliver Pullig
    Günter Stein
    Gert Hein
    Rheumatology International, 2005, 25 : 411 - 413
  • [2] Relationship between serum-soluble receptor for advanced glycation end products (sRAGE) and disease activity in rheumatoid arthritis patients
    Jafari Nakhjavani, Mohammad Reza
    Jafarpour, Mahdi
    Ghorbanihaghjo, Amir
    Abedi Azar, Sima
    Malek Mahdavi, Aida
    MODERN RHEUMATOLOGY, 2019, 29 (06) : 943 - 948
  • [3] Low Soluble Receptor for Advanced Glycation End Products Precedes and Predicts Cardiometabolic Events in Women With Rheumatoid Arthritis
    Nadali, Mitra
    Lyngfelt, Lovisa
    Erlandsson, Malin C.
    Silfversward, Sofia Toyra
    Andersson, Karin M. E.
    Bokarewa, Maria, I
    Pullerits, Rille
    FRONTIERS IN MEDICINE, 2021, 7
  • [4] Receptor for advanced glycation end products Glycine 82 Serine polymorphism and risk of cardiovascular events in rheumatoid arthritis
    Lisa Carroll
    Ian H Frazer
    Malcolm Turner
    Thomas H Marwick
    Ranjeny Thomas
    Arthritis Research & Therapy, 9
  • [5] Advanced glycation end-products inhibition improves endothelial dysfunction in rheumatoid arthritis
    Syngle, Ashit
    Vohra, Kanchan
    Garg, Nidhi
    Kaur, Ladbans
    Chand, Prem
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2012, 15 (01) : 45 - 55
  • [6] Advanced glycation end products, advanced oxidation protein products, and ferric reducing ability of plasma in patients with rheumatoid arthritis: a focus on activity scores
    Seyed Reza Najafizadeh
    Khatereh Amiri
    Maryam Moghaddassi
    Shaghayegh Khanmohammadi
    Hossein Mirmiranpour
    Manouchehr Nakhjavani
    Clinical Rheumatology, 2021, 40 : 4019 - 4026
  • [7] Advanced glycation end products, advanced oxidation protein products, and ferric reducing ability of plasma in patients with rheumatoid arthritis: a focus on activity scores
    Najafizadeh, Seyed Reza
    Amiri, Khatereh
    Moghaddassi, Maryam
    Khanmohammadi, Shagayegh
    Mirmiranpour, Hossein
    Nakhjavani, Manouchehr
    CLINICAL RHEUMATOLOGY, 2021, 40 (10) : 4019 - 4026
  • [8] Expression of advanced glycation end products and their receptor in skin from patients with systemic sclerosis with and without calcinosis
    Davies, Christine A.
    Herrick, Ariane L.
    Cordingley, Lis
    Freemont, Anthony J.
    Jeziorska, Maria
    RHEUMATOLOGY, 2009, 48 (08) : 876 - 882
  • [9] Characterisation of the cannabinoid receptor system in synovial tissue and fluid in patients with osteoarthritis and rheumatoid arthritis
    Denise Richardson
    Richard G Pearson
    Nisha Kurian
    M Liaque Latif
    Michael J Garle
    David A Barrett
    David A Kendall
    Brigitte E Scammell
    Alison J Reeve
    Victoria Chapman
    Arthritis Research & Therapy, 10
  • [10] Rheumatoid arthritis: links with cardiovascular disease and the receptor for advanced glycation end productsRheumatoide Arthritis: Zusammenhänge zwischen kardiovaskulären Erkrankungen und dem "Advanced Glycation End Product Receptor"
    Lisa Carroll
    Suad Hannawi
    Thomas Marwick
    Ranjeny Thomas
    Wiener Medizinische Wochenschrift, 2006, 156 (1-2) : 42 - 52